Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006;2006(3):19365.
doi: 10.1155/JBB/2006/19365.

Mechanisms of neuronal death in synucleinopathy

Atsushi Takeda  1 , Takafumi Hasegawa, Michiko Matsuzaki-Kobayashi, Naoto Sugeno, Akio Kikuchi, Yasuto Itoyama, Katsutoshi Furukawa
Affiliations

Mechanisms of neuronal death in synucleinopathy

Atsushi Takeda et al. J Biomed Biotechnol. 2006.

Abstract

alpha-synuclein is a key molecule in the pathogenesis of synucleinopathy including Parkinson's disease and multiple system atrophy. In this mini-review, we mainly focus on recent data obtained from cellular models of synucleinopathy and discuss the possible mechanisms of neurodegeneration. Recent progress suggests that the aggregate formation of alpha-synuclein is cytoprotective and that its precursor oligomer (protofibril) may be cytotoxic. The catechol-derived quinones are the candidate molecules that facilitate the oligomer formation of alpha-synuclein. Furthermore, the cellular membranes are shown to be the primary targets injured by mutant alpha-synucleins, and the mitochondrial dysfunction seems to be an initial step in the neuronal death.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Possible mechanisms of neurodegeneration in synucleinopathy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Eriksen JL, Dawson TM, Dickson DW, Petrucelli L. Caught in the act: α-synuclein is the culprit in Parkinson's disease. Neuron. 2003;40(3):453–456. - PubMed
    1. Dev KK, Hofele K, Barbieri S, Buchman VL, Van der Putten H. Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology. 2003;45(1):14–44. - PubMed
    1. Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC. α-synuclein cooperates with CSPα in preventing neurodegeneration. Cell. 2005;123(3):383–396. - PubMed
    1. Munoz E, Oliva R, Obach V, et al. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the α-synuclein gene in early onset patients. Neuroscience Letters. 1997;235(1-2):57–60. - PubMed
    1. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genetics. 1998;18(2):106–108. - PubMed

LinkOut - more resources